Reactome | AZ5104 [cytosol]

Schema > ChemicalDrug > Entries

compartment	[Compartment:70101] cytosol
componentOf	[Complex:R-HSA-9665136] ERBB2 KD mutants:AZ5104 [plasma membrane] - Homo sapiens
created	[InstanceEdit:9649873] Orlic-Milacic, Marija, 2019-06-17
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992
dbId	9649879
disease	[Disease:1500689] cancer
displayName	AZ5104 [cytosol]
inDisease	true
maxDepth	1
memberOf	[DefinedSet:R-ALL-9652360] lapatinib, neratinib, afatinib, AZ5104, tesevatinib, canertinib, sapitinib, CP-724714, AEE78 [cytosol] [DefinedSet:R-ALL-9665127] TKIs (ERBB2) [cytosol]
modified	[InstanceEdit:9735472] Jassal, Bijay, 2021-06-28
name	AZ5104
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:11580] AZ5104 [Guide to Pharmacology:11580]
schemaClass	ChemicalDrug
stId	R-ALL-9649879
updateTrackers	[UpdateTracker:9902659] Update Tracker - [ChemicalDrug:9649879] AZ5104 [cytosol] - v78:[add_removeReferenceEntity]

(updatedInstance)	[UpdateTracker:9902659] Update Tracker - [ChemicalDrug:9649879] AZ5104 [cytosol] - v78:[add_removeReferenceEntity]
(hasComponent)	[Complex:R-HSA-9665136] ERBB2 KD mutants:AZ5104 [plasma membrane]
(hasMember)	[DefinedSet:R-ALL-9665127] TKIs (ERBB2) [cytosol] [DefinedSet:R-ALL-9652360] lapatinib, neratinib, afatinib, AZ5104, tesevatinib, canertinib, sapitinib, CP-724714, AEE78 [cytosol]